Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-27 @ 3:00 PM
Study NCT ID:
NCT03013504
Status:
COMPLETED
Last Update Posted:
2024-11-06
First Post:
2016-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients
Sponsor:
Prestige Biopharma Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-29
First Submit QC Date:
None
Study First Post Date:
2017-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-04
Last Update Post Date:
2024-11-06
Last Update Post Date Type:
ACTUAL